Minisymposium der SCS, SCS / Division of Medicinal Chemistry
A bi-annual minisymposium organized by the DMCCB of the Swiss Chemical Society on a cutting edge topic. This years topic is «Epigenetic Targets: New opportunities for medicinal chemistry»
Confirmed Speakers:
- Neil Pegg, Cellcentric Cambridge, UK, «Epigenetics: Providing new targets for drug discovery»
- Andre Fischer, University og Goetttingen / Max Planck Institute for Experimental Medicine, Germany, «Epigenetic mechanisms in neurodegenerative diseases»
- Chun-Wa Chung, Inhibitors of epigenetic bromodomains extend the druggable genome, «Exploiting epigenetic bromodomains: From phenotypic to fragment based drug discovery»
- Michael G. Schultz, Novartis Institute for Biomedical Research, Cambridge USA, «HDAC Inhibitors: Not for the faint of heart - or are they?»
Contact:
Karl-Heinz Altmann, karl-heinz.altmann@pharma.ethz.ch